All serious adverse events were rare, and those that have emerged mostly related to Crohn’s disease itself.The researchers believe that important because important because it the the self – treatment of patients with Crohn’s disease. ‘Our findings are important because of the use of alternative medicines in general and omega-3 free fatty acid formulations is particularly prevalent in patients with chronic inflammatory bowel disease achat viagra en france . This may be due to in part to the spread the benefits in[a study by Belluzzi et al]. Given the negative results in the EPIC study and observed[a study by Lorenz-Meyer et al], we do not support this practice, since patients with Crohn’s disease who were at risk for a relapse better served by taking medications known effectiveness , ‘they write, ‘they write.
To try correct this, Brian G. Made of Robarts Research Institute, University of Western Ontario, Ontario, and colleagues two large studies with high doses of omega-3 free fatty acids as a treatment Crohn ‘s disease patients in remission were. The study, called the Epanova Program in Crohn’s Study 1 and 2[ EPIC-1 and EPIC – 2] were conducted between January 2003 and February 2007 at 98 different centers in Canada, Israel and the United States All There were 363 and 375 patients are involved. All with Crohn’s disease at the time at the time Patients were randomly assigned in approximately equal numbers to a group administered four grams per day of omega-3 fatty acids or a placebo, to be taken for up to 58 weeks either. Important to was no significant difference in relapse rates between the two treatment groups in one of the studies -. In EPIC-1, 54 patients experienced with the fatty acids and 62 placebo-treated patients, a clinical relapse. The amount of patients in whom recurrence was within 360 days of the omega – 3 group at 31, compared with 35.7 percent in of the placebo group. EPIC-2 had 84 patients with with omega-3 fatty acids and 94 who took the placebo experienced relapse. The rate of patients with recurrence within 360 days of the omega – 3 group was in at 47, as opposed to 48.8 percent in the placebo group. Continue reading